Although cancer screening saves lives, it comes at a high cost. Americans spend at least $43 billion each year on tests that check for five major cancers, according to a new study published in the Annals of Internal Medicine.
Researchers focused on screenings for breast, cervical, colon, lung and prostate cancers, using data from 2021. Dr. Michael Halpern of the National Cancer Institute's health care delivery research program and lead author of the study told the New York Times that his team was surprised by the high cost.
The study also found that the $43.2 billion total was less than the reported cost of cancer treatment within the first 12 months after diagnosis, an indication of the cost-effectiveness of early screening. Karen Knudsen, CEO of the American Cancer Society, believes the results justify the cost.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
